Titan Biotech Ltd.
BSE: 524717 | Sector: Health care |
NSE: N.A. | ISIN Code: INE150C01011 |
BSE 00:00 | 24 Jun | 213.45 |
1.60 (0.76%) |
OPEN
211.00 |
HIGH
217.90 |
LOW
210.50 |
NSE 05:30 | 01 Jan | Titan Biotech Ltd |
OPEN | 211.00 |
PREVIOUS CLOSE | 211.85 |
VOLUME | 3652 |
52-Week high | 423.60 |
52-Week low | 205.40 |
P/E | 8.13 |
Mkt Cap.(Rs cr) | 176 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Titan Biotech Ltd. (TITANBIOTECH) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 824.10 | 197,726.31 | 12,803.21 | 2,139.70 | 32,510.54 |
Divi's Lab. | 3,680.40 | 97,696.22 | 6,798.61 | 1,954.72 | 9,297.17 |
Cipla | 933.40 | 75,316.05 | 13,900.58 | 2,468.28 | 20,166.89 |
Dr Reddy's Labs | 4,308.75 | 71,714.84 | 13,349.10 | 2,186.40 | 18,266.10 |
Apollo Hospitals | 3,835.60 | 55,148.26 | 9,153.00 | 105.00 | 8,226.00 |
Torrent Pharma. | 2,875.50 | 48,659.21 | 6,450.83 | 1,137.85 | 10,618.60 |
Gland Pharma | 2,643.70 | 43,541.74 | 3,462.88 | 997.01 | 5,909.86 |
Piramal Enterp. | 1,651.10 | 39,403.50 | 1,824.70 | 39.90 | 29,983.67 |
Biocon | 326.90 | 39,247.61 | 2,028.40 | 280.50 | 8,024.20 |
Abbott India | 18,088.00 | 38,437.00 | 4,310.02 | 690.69 | 2,844.49 |
Zydus Lifesci. | 353.70 | 36,208.27 | 7,790.40 | 1,476.20 | 16,841.70 |
Max Healthcare | 371.90 | 36,060.54 | 1,079.68 | -164.45 | 6,439.88 |
Alkem Lab | 3,003.85 | 35,911.03 | 7,219.68 | 1,685.08 | 9,195.63 |
Aurobindo Pharma | 526.40 | 30,841.78 | 15,823.68 | 3,112.91 | 19,952.13 |
Lupin | 629.95 | 28,634.38 | 11,055.93 | 1,258.62 | 19,354.36 |
Glaxosmi. Pharma | 1,499.75 | 25,407.27 | 3,193.74 | 357.57 | 1,798.50 |
Laurus Labs | 466.60 | 25,072.75 | 4,707.04 | 750.09 | 5,178.13 |
Syngene Intl. | 568.05 | 22,803.23 | 2,179.40 | 403.70 | 4,022.40 |
Ipca Labs. | 888.95 | 22,552.66 | 5,139.16 | 1,140.77 | 5,028.39 |
Pfizer | 4,102.30 | 18,768.02 | 2,238.55 | 497.61 | 2,494.06 |
Quick Links for Titan Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices